» Articles » PMID: 31191687

Downregulation of an Evolutionary Young MiR-1290 in an IPSC-Derived Neural Stem Cell Model of Autism Spectrum Disorder

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2019 Jun 14
PMID 31191687
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The identification of several evolutionary young miRNAs, which arose in primates, raised several possibilities for the role of such miRNAs in human-specific disease processes. We previously have identified an evolutionary young miRNA, miR-1290, to be essential in neural stem cell proliferation and neuronal differentiation. Here, we show that miR-1290 is significantly downregulated during neuronal differentiation in reprogrammed induced pluripotent stem cell- (iPSC-) derived neurons obtained from idiopathic autism spectrum disorder (ASD) patients. Further, we identified that miR-1290 is actively released into extracellular vesicles. Supplementing ASD patient-derived neural stem cells (NSCs) with conditioned media from differentiated control-NSCs spiked with "artificial EVs" containing synthetic miR-1290 oligonucleotides significantly rescued differentiation deficits in ASD cell lines. Based on our earlier published study and the observations from the data presented here, we conclude that miR-1290 regulation could play a critical role during neuronal differentiation in early brain development.

Citing Articles

Extracellular Vesicle-Enriched miRNA-Biomarkers Show Improved Utility for Detecting Alzheimer's Disease Dementia and Medial Temporal Atrophy.

Chai Y, Strohm L, Zhu Y, Chia R, Chong J, Suresh D J Alzheimers Dis. 2024; 99(4):1317-1331.

PMID: 38788066 PMC: 11191453. DOI: 10.3233/JAD-230572.


A systematic review of non-coding RNA genes with differential expression profiles associated with autism spectrum disorders.

Stott J, Wright T, Holmes J, Wilson J, Griffiths-Jones S, Foster D PLoS One. 2023; 18(6):e0287131.

PMID: 37319303 PMC: 10270643. DOI: 10.1371/journal.pone.0287131.


miRNAs as Predictors of Barrier Integrity.

Bovari-Biri J, Garai K, Banfai K, Csongei V, Pongracz J Biosensors (Basel). 2023; 13(4).

PMID: 37185497 PMC: 10136429. DOI: 10.3390/bios13040422.


Extracellular Vesicles in Mental Disorders: A State-of-art Review.

Kong L, Zhang D, Huang S, Lai J, Lu L, Zhang J Int J Biol Sci. 2023; 19(4):1094-1109.

PMID: 36923936 PMC: 10008693. DOI: 10.7150/ijbs.79666.


Decoding microRNAs in autism spectrum disorder.

Li J, Xu X, Liu J, Zhang S, Tan X, Li Z Mol Ther Nucleic Acids. 2022; 30:535-546.

PMID: 36457702 PMC: 9685394. DOI: 10.1016/j.omtn.2022.11.005.


References
1.
Girao da Cruz M, Simoes S, de Lima M . Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons. Exp Neurol. 2004; 187(1):65-75. DOI: 10.1016/j.expneurol.2003.12.013. View

2.
Berezikov E, Thuemmler F, van Laake L, Kondova I, Bontrop R, Cuppen E . Diversity of microRNAs in human and chimpanzee brain. Nat Genet. 2006; 38(12):1375-7. DOI: 10.1038/ng1914. View

3.
Makeyev E, Zhang J, Carrasco M, Maniatis T . The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell. 2007; 27(3):435-48. PMC: 3139456. DOI: 10.1016/j.molcel.2007.07.015. View

4.
Kim H, Rosenfeld M . Epigenetic control of stem cell fate to neurons and glia. Arch Pharm Res. 2010; 33(10):1467-73. DOI: 10.1007/s12272-010-1001-z. View

5.
Kantojarvi K, Kotala I, Rehnstrom K, Ylisaukko-Oja T, Vanhala R, von Wendt T . Fine mapping of Xq11.1-q21.33 and mutation screening of RPS6KA6, ZNF711, ACSL4, DLG3, and IL1RAPL2 for autism spectrum disorders (ASD). Autism Res. 2011; 4(3):228-33. DOI: 10.1002/aur.187. View